As of mid-September 2026, the CDC has confirmed 3,471 measles cases nationwide, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Sustained transmission stems primarily from large, ongoing outbreaks in Pennsylvania (over 700 cases), South Carolina, Utah, and several other states, with 95% of cases occurring in unvaccinated or unknown-status individuals and 95% linked to outbreaks. Most infections are locally acquired rather than imported, reflecting community-level immunity gaps amid declining MMR vaccination rates. Hospitalizations stand at about 9%, and while Pennsylvania has reported four measles-associated deaths, CDC national tallies show zero for 2026 pending standardized review. Weekly CDC surveillance updates and state reporting will continue to shape the final 2026 total through year-end.
基於Polymarket數據的AI實驗性摘要。這不是交易建議，也不影響該市場的結算方式。 · 更新於2026年美國麻疹病例？
2026年美國麻疹病例？
$7,968,374 交易量
$7,968,374 交易量
2026-12-31
↑3.5千
100%
↑4k
100%
↑4.5k
87%
↑4.5k
82%
↑5k
67%
↑7.5k
14%
↑10k
8%
↑12.5k
2%
$7,968,374 交易量
$7,968,374 交易量
2026-12-31
↑3.5千
$15,824 交易量
100%
↑4k
$241,336 交易量
100%
↑4.5k
$4,353 交易量
87%
↑4.5k
$64,000 交易量
82%
↑5k
$243,324 交易量
67%
↑7.5k
$195,923 交易量
14%
↑10k
$6,526,457 交易量
8%
↑12.5k
$357,202 交易量
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-September 2026, the CDC has confirmed 3,471 measles cases nationwide, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Sustained transmission stems primarily from large, ongoing outbreaks in Pennsylvania (over 700 cases), South Carolina, Utah, and several other states, with 95% of cases occurring in unvaccinated or unknown-status individuals and 95% linked to outbreaks. Most infections are locally acquired rather than imported, reflecting community-level immunity gaps amid declining MMR vaccination rates. Hospitalizations stand at about 9%, and while Pennsylvania has reported four measles-associated deaths, CDC national tallies show zero for 2026 pending standardized review. Weekly CDC surveillance updates and state reporting will continue to shape the final 2026 total through year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
市場開放時間： Feb 16, 2026, 11:51 AM ET
交易量
$7,968,374結束日期
2027-01-01市場開放時間
Feb 16, 2026, 11:51 AM ET已提議結果: 是
無爭議
最終結果: 是
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-September 2026, the CDC has confirmed 3,471 measles cases nationwide, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Sustained transmission stems primarily from large, ongoing outbreaks in Pennsylvania (over 700 cases), South Carolina, Utah, and several other states, with 95% of cases occurring in unvaccinated or unknown-status individuals and 95% linked to outbreaks. Most infections are locally acquired rather than imported, reflecting community-level immunity gaps amid declining MMR vaccination rates. Hospitalizations stand at about 9%, and while Pennsylvania has reported four measles-associated deaths, CDC national tallies show zero for 2026 pending standardized review. Weekly CDC surveillance updates and state reporting will continue to shape the final 2026 total through year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
交易量
$7,968,374結束日期
2027-01-01市場開放時間
Feb 16, 2026, 11:51 AM ET已提議結果: 是
無爭議
最終結果: 是
As of mid-September 2026, the CDC has confirmed 3,471 measles cases nationwide, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Sustained transmission stems primarily from large, ongoing outbreaks in Pennsylvania (over 700 cases), South Carolina, Utah, and several other states, with 95% of cases occurring in unvaccinated or unknown-status individuals and 95% linked to outbreaks. Most infections are locally acquired rather than imported, reflecting community-level immunity gaps amid declining MMR vaccination rates. Hospitalizations stand at about 9%, and while Pennsylvania has reported four measles-associated deaths, CDC national tallies show zero for 2026 pending standardized review. Weekly CDC surveillance updates and state reporting will continue to shape the final 2026 total through year-end.
基於Polymarket數據的AI實驗性摘要。這不是交易建議，也不影響該市場的結算方式。 · 更新於
警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions